Skip to content
10-Q

Quarterly Report

Biohaven Ltd. BHVN

0001935979-25-000054

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 102.11M sh
Stockholders Equity Q1 2025 · Mar 31, 2025 $259.5M
Stockholders Equity Q1 2025 · Dec 31, 2024 $423.44M
Current Liabilities Q1 2025 · Mar 31, 2025 $164.03M
Current Liabilities Q1 2025 · Dec 31, 2024 $154.23M
Total Liabilities Q1 2025 · Mar 31, 2025 $199.45M
Total Liabilities Q1 2025 · Dec 31, 2024 $191.67M
Current Assets Q1 2025 · Mar 31, 2025 $382.76M
Current Assets Q1 2025 · Dec 31, 2024 $538.47M
Total Assets Q1 2025 · Mar 31, 2025 $458.95M
Total Assets Q1 2025 · Dec 31, 2024 $615.11M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $99.13M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $182.71M
Shares Diluted Q1 2025 · Mar 31, 2024 81.6M sh
Capex Q1 2025 · Mar 31, 2024 $440K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$102.64M
Eps Diluted Q1 2025 · Mar 31, 2024 −$2.20
Eps Basic Q1 2025 · Mar 31, 2024 −$2.20
Sga Expense Q1 2025 · Mar 31, 2024 $27.27M
Rd Expense Q1 2025 · Mar 31, 2024 $155.97M
Net Income Q1 2025 · Mar 31, 2024 −$179.5M
Operating Income Q1 2025 · Mar 31, 2024 −$183.24M